Cue Biopharma, Inc. Quarterly Operating Margin in % from Q4 2019 to Q2 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Cue Biopharma, Inc. quarterly/annual Operating Margin history and growth rate from Q4 2019 to Q2 2024.
  • Cue Biopharma, Inc. Operating Margin for the quarter ending June 30, 2024 was -582 %, a 80.3% increase year-over-year.
  • Cue Biopharma, Inc. annual Operating Margin for 2023 was -950 %, a 77.8% increase from 2022.
  • Cue Biopharma, Inc. annual Operating Margin for 2022 was -4.28K %, a 1361% decline from 2021.
  • Cue Biopharma, Inc. annual Operating Margin for 2021 was -293 %, a 79.5% increase from 2020.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -582 +2.37K +80.3% Apr 1, 2024 Jun 30, 2024
Q1 2024 -733 +11.4K +94% Jan 1, 2024 Mar 31, 2024
Q4 2023 -950 +3.33K +77.8% Oct 1, 2023 Dec 31, 2023
Q3 2023 -1.39K -898 -182% Jul 1, 2023 Sep 30, 2023
Q2 2023 -2.95K -2.54K -615% Apr 1, 2023 Jun 30, 2023
Q1 2023 -12.1K -11.8K -3739% Jan 1, 2023 Mar 31, 2023
Q4 2022 -4.28K -3.98K -1361% Oct 1, 2022 Dec 31, 2022
Q3 2022 -495 +159 +24.3% Jul 1, 2022 Sep 30, 2022
Q2 2022 -413 +390 +48.6% Apr 1, 2022 Jun 30, 2022
Q1 2022 -316 +855 +73% Jan 1, 2022 Mar 31, 2022
Q4 2021 -293 +1.14K +79.5% Oct 1, 2021 Dec 31, 2021
Q3 2021 -654 +502 +43.4% Jul 1, 2021 Sep 30, 2021
Q2 2021 -803 +196 +19.6% Apr 1, 2021 Jun 30, 2021
Q1 2021 -1.17K -209 -21.8% Jan 1, 2021 Mar 31, 2021
Q4 2020 -1.43K -365 -34.3% Oct 1, 2020 Dec 31, 2020
Q3 2020 -1.16K Jul 1, 2020 Sep 30, 2020
Q2 2020 -999 Apr 1, 2020 Jun 30, 2020
Q1 2020 -961 Jan 1, 2020 Mar 31, 2020
Q4 2019 -1.06K Oct 1, 2019 Dec 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.